TY  - JOUR
AU  - Rodríguez-Hernández, María A
AU  - González, Raúl
AU  - de la Rosa, Ángel J
AU  - Gallego, Paloma
AU  - Ordóñez, Raquel
AU  - Navarro-Villarán, Elena
AU  - Contreras, Laura
AU  - Rodríguez-Arribas, Mario
AU  - González-Gallego, Javier
AU  - Álamo-Martínez, José M
AU  - Marín-Gómez, Luís M
AU  - Del Campo, José A
AU  - Quiles, José L
AU  - Fuentes, José M
AU  - de la Cruz, Jesús
AU  - Mauriz, José L
AU  - Padillo, Francisco J
AU  - Muntané, Jordi
PY  - 2018
DO  - 10.1002/jcp.26855
UR  - http://hdl.handle.net/10668/12863
T2  - Journal of cellular physiology
AB  - Sorafenib is the unique accepted molecular targeted drug for the treatment of patients in advanced stage of hepatocellular carcinoma. The current study evaluated cell signaling regulation of endoplasmic reticulum (ER) stress, c-Jun-N-terminal kinase...
LA  - en
KW  - 5′AMP-activated protein kinase (AMPK)
KW  - Bcl-2
KW  - apoptosis
KW  - autophagy
KW  - endoplasmic reticulum stress
KW  - mammalian target of rapamycin (mTOR)
KW  - Animals
KW  - Apoptosis
KW  - Autophagy
KW  - Biomarkers, Tumor
KW  - Caspase 3
KW  - Endoplasmic Reticulum Stress
KW  - Gene Expression Regulation, Neoplastic
KW  - Hep G2 Cells
KW  - Humans
KW  - JNK Mitogen-Activated Protein Kinases
KW  - Liver Neoplasms
KW  - Mice
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - Neoplasm Proteins
KW  - Signal Transduction
KW  - Sorafenib
KW  - Transcription Factor CHOP
KW  - Xenograft Model Antitumor Assays
TI  - Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.
TY  - research article
VL  - 234
ER  -